Cargando…
GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
Recent evaluations of the GeneXpert MTB/RIF assay for the simultaneous detection of Mycobacterium tuberculosis and drug resistance in less than 2 h have stimulated tremendous enthusiasm. This is the breakthrough that tuberculosis (TB) control has been waiting for. In this (retrospective review) case...
Autores principales: | Saeed, Muhammad, Hussain, Shahida, Riaz, Saba, Rasheed, Farhan, Ahmad, Maqsood, Iram, Shagufta, Arif, Mizna, Rahmani, Tariq Hamid, Anwar, Ambereen Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874587/ https://www.ncbi.nlm.nih.gov/pubmed/33817234 http://dx.doi.org/10.1515/biol-2020-0052 |
Ejemplares similares
-
GeneXpert technology: A breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours
por: Saeed, Muhammad, et al.
Publicado: (2017) -
Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021) -
Rapid diagnosis of tuberculosis using Xpert MTB/RIF assay - Report from a developing country
por: Iram, Shagufta, et al.
Publicado: (2015) -
GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011) -
GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)